Not finding it? Sign in to also search OpenAlex live.
-
Usability and feasibility assessment of the Huntington Support App (HD-eHelp study): a mixed-methods multi-study report2025 BMC Digital Health article Health Professions Mobile Health and mHealth Applications Open access
Pearl J. C. van Lonkhuizen, Leanne Slutter, Eline M. Meijer, Erik van Duijn, Susanne Tamara de Bot, Niko Vegt, +29 more
0citations -
Advancing the C 4 low-temperature oxidation chemistry through species measurements in a rapid compression machine, Part A: 1-Butene2024 Combustion and Flame article Chemical Engineering Advanced Combustion Engine Technologies Open access
Jesus Caravaca-Vilchez, Jiaxin Liu, Pengzhi Wang, Yuki Murakami, Henry J. Curran, Karl Alexander Heufer
0citations -
Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE study2024 Annals of the Rheumatic Diseases article Medicine Systemic Lupus Erythematosus Research Open access
Cynthia B. Aranow, Cornelia F Allaart, Zahir Amoura, Ian N Bruce, Patricia C. Cagnoli, Walter Winn Chatham, +15 more
55citations -
Clinical evaluation of late outcomes in Dutch childhood cancer survivors: Methodology of the DCCSS LATER 2 study2023 Pediatric Blood & Cancer article Medicine Childhood Cancer Survivors' Quality of Life Open access
Elizabeth A. M. Feijen, Jop C. Teepen, Eline van Dulmen‐den Broeder, Marry M. van den Heuvel‐Eibrink, Margriet van der Heiden‐van der Loo, Helena J. H. van der Pal, +17 more
41citations -
Replication of 10 novel loci involved in human plasma protein N-glycosylation using MALDI-MS and UHPLC-FD data2026 Glycobiology article Biochemistry, Genetics and Molecular Biology Glycosylation and Glycoproteins Research Open access
Anna N. Timoshchuk, Annemieke Naber, Roderick C. Slieker, Anna G. Soplenkova, Denis E. Maslov, Nadezhda A. Potapova, +8 more
1citations -
Critical infrastructure networks in flood risk management : integration of flood risk analysis methods for networks, consideration of network-specific measures and challenges for data availability0citations
-
Murine Model of Glomerular Thrombotic Microangiopathy Results in Glomerular Endothelial-to-Mesenchymal Transition2024 Journal of the American Society of Nephrology article Immunology and Microbiology Complement system in diseases
Patrick Droste, Sonja Djudjaj, Barbara M. Klinkhammer, Eva Miriam Buhl, Elisabeth Kemter, Peter Boor
0citations -
Post Hoc Analysis of the Effect of Pegcetacoplan Treatment of Patients with Paroxysmal Nocturnal Hemoglobinuria and Baseline Hemoglobin Levels Greater Than 10 Grams per Deciliter2021 Blood conference-abstract Immunology and Microbiology Complement system in diseases Open access
Jens Panse, Nicolas Daguindau, Sonia Okuyama, Régis Peffault de Latour, Philippe Schafhausen, Nicole Straetmans, +5 more
1citations -
P828: NORMALIZATION OF HEMATOLOGIC AND HEALTH-RELATED QUALITY OF LIFE MARKERS IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA TREATED WITH PEGCETACOPLAN AND BASELINE HEMOGLOBIN AT OR ABOVE 10 G/DL
Jens Panse, Nicolas Daguindau, Sonia Okuyama, Régis Peffault de Latour, Philippe Schafhausen, Nicole Straetmans, +4 more
0citations -
Eculizumab Rescue Therapy in Patients With Recurrent Atypical Hemolytic Uremic Syndrome After Kidney Transplantation2023 Kidney International Reports article Immunology and Microbiology Complement system in diseases Open access
Caroline Duineveld, Romy N. Bouwmeester, Kioa Lente Wijnsma, Fréderike J. Bemelman, Joost W van der Heijden, Stefan P. Berger, +14 more
21citations -
Moving toward Individual Treatment Goals with Pegcetacoplan in Patients with PNH and Impaired Bone Marrow Function2024 International Journal of Molecular Sciences article Immunology and Microbiology Complement system in diseases Open access
Jeff Szer, Jens Panse, Austin Gladston Kulasekararaj, Monika Oliver, Bruno Fattizzo, J Nishimura, +3 more
4citations -
Efficacy, Safety, and Quality of Life of Pegcetacoplan in Japanese Patients with Paroxysmal Nocturnal Hemoglobinuria Treated within the Phase 3 PEGASUS Trial2024 Acta Haematologica article Immunology and Microbiology Complement system in diseases Open access
Hisakazu Nishimori, Hideyuki Nakazawa, Shinobu Tamura, Toshiki Uchida, Kensuke Usuki, Johan Szamosi, +3 more
4citations -
Oral Iptacopan Monotherapy Leads to Long-Term Improvements in Patient (Pt)-Reported Health-Related Quality of Life (HRQoL) and Investigator-Assessed Signs and Symptoms of Paroxysmal Nocturnal Hemoglobinuria (PNH): 48-Week (Wk) Results from the Phase III APPLY-PNH and APPOINT-PNH Trials
Antonio Maria Risitano, Bing Han, Austin Gladston Kulasekararaj, Yasutaka Ueda, Phillip Scheinberg, Jaroslaw Pawel Maciejewski, +7 more
2citations -
S182: ORAL IPTACOPAN MONOTHERAPY INCREASES PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) RED BLOOD CELL CLONE SIZE VIA CONTROL OF INTRA- AND EXTRAVASCULAR HEMOLYSIS IN ANTI-C5-TREATED PNH PATIENTS WITH ANEMIA
Antonio Maria Risitano, Alexander Röth, Austin Gladston Kulasekararaj, Phillip Scheinberg, Yutaka Ueda, Eros Di Bona, +28 more
2citations -
Incremental Effectiveness of Iptacopan Compared with C5 Inhibitors in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria: Results from a Modelling Analysis2024 Blood conference-abstract Immunology and Microbiology Complement system in diseases Open access
Shreyans Gandhi, Régis Peffault de Latour, Katharina Pannagl, Maria‐Magdalena Balp, Anggie Wiyani, Cheryl Druchok, +1 more
0citations